Neurology News

The global response to the COVID-19 pandemic has produced tens of thousands of tons of extra health care waste that many facilities are not equipped to handle, according to WHO.

Clinicians who treat patients with chimeric antigen receptor T cells have become adept at identifying and treating acute neurotoxicity, a common adverse event associated with the therapy.

Many millennial physicians have known about bitcoin and other cryptocurrencies for years.

Certain antihypertensive medications may help prevent cognitive decline, according to results of a cohort study published in JAMA Network Open.

Cognito Therapeutics and Providence Health Plan will collaborate on a phase 3 study of a noninvasive therapy for patients with mild cognitive impairment, according to a release.

Presence of hyperglycemia at hospital admission for stroke was linked with elevated risk for subsequent stroke by 90 days, an increase that dual antiplatelet therapy seemingly failed to curtail, researchers reported.

New data show that Suki, a voice-activated and artificial intelligence-based tool that helps physicians with their note-taking process, continues to dramatically reduce the time that physicians spend on documentation.

Healio’s most-viewed neurology stories in January highlight several FDA developments, a Medicare proposal to limit Aduhelm coverage and a study on the role of Epstein-Barr virus infection in MS.

Neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein-antibody associated disease incur significant costs for individuals, their families and for society, according to study results published in Neurology.

Many adults with a traumatic brain injury had a persistent form of insomnia for up to 12 months, according to a prospective cohort study published in JAMA Network Open.